{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:07:49Z","timestamp":1790356069542,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10147-026-03153-5","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:47:45Z","timestamp":1785862065000},"page":"2449-2459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical utility and cost-effectiveness of universal tumor screening to identify Lynch syndrome in patients with stage II\/III colorectal cancer: a prospective observational study in Japan"],"prefix":"10.1007","volume":"31","author":[{"given":"Takahiro","family":"Yoshioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ataru","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kuwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumie","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiwamu","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"3153_CR1","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1056\/NEJM199805213382101","volume":"338","author":"LA Aaltonen","year":"1998","unstructured":"Aaltonen LA, Salovaara R, Kristo P et al (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338:1481\u20131487","journal-title":"N Engl J Med"},{"key":"3153_CR2","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1200\/JCO.2000.18.11.2193","volume":"18","author":"R Salovaara","year":"2000","unstructured":"Salovaara R, Loukola A, Kristo P et al (2000) Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 18:2193\u20132200","journal-title":"J Clin Oncol"},{"key":"3153_CR3","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1056\/NEJMoa043146","volume":"352","author":"H Hampel","year":"2005","unstructured":"Hampel H, Frankel WL, Martin E et al (2005) Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352:1851\u20131860","journal-title":"N Engl J Med"},{"key":"3153_CR4","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1056\/NEJMoa053493","volume":"354","author":"RA Barnetson","year":"2006","unstructured":"Barnetson RA, Tenesa A, Farrington SM et al (2006) Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 354:2751\u20132763","journal-title":"N Engl J Med"},{"key":"3153_CR5","first-page":"455","volume":"19","author":"HT Lynch","year":"2005","unstructured":"Lynch HT, Lynch JF (2005) What the physician needs to know about Lynch syndrome: an update. Oncol (Williston Park) 19:455\u2013463 discussion 463\u2009\u2013\u2009454","journal-title":"Oncol (Williston Park)"},{"key":"3153_CR6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1053\/j.gastro.2014.04.001","volume":"147","author":"FM Giardiello","year":"2014","unstructured":"Giardiello FM, Allen JI, Axilbund JE et al (2014) Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology 147:502\u2013526","journal-title":"Gastroenterology"},{"key":"3153_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-020-00226-w","author":"G Kunnackal John","year":"2021","unstructured":"Kunnackal John G, Das Villgran V, Caufield-Noll C et al (2021) Comparison of universal screening in major lynch-associated tumors: a systematic review of literature. Fam Cancer doi. https:\/\/doi.org\/10.1007\/s10689-020-00226-w","journal-title":"Fam Cancer doi"},{"key":"3153_CR8","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1001\/jama.2012.13088","volume":"308","author":"L Moreira","year":"2012","unstructured":"Moreira L, Balaguer F, Lindor N et al (2012) Identification of Lynch syndrome among patients with colorectal cancer. JAMA 308:1555\u20131565","journal-title":"JAMA"},{"key":"3153_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-020-00206-0","author":"G Kunnackal John","year":"2020","unstructured":"Kunnackal John G, Das Villgran V, Caufield-Noll C et al (2020) Worldwide variation in lynch syndrome screening: case for universal screening in low colorectal cancer prevalence areas. Fam Cancer. https:\/\/doi.org\/10.1007\/s10689-020-00206-0","journal-title":"Fam Cancer"},{"key":"3153_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41436-018-0025-5","volume":"21","author":"SD Grosse","year":"2019","unstructured":"Grosse SD (2019) Is universal tumor testing for Lynch syndrome cost-effective? It depends! Genet Med 21:252\u2013253","journal-title":"It depends! Genet Med"},{"key":"3153_CR11","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/gim.2017.244","volume":"20","author":"M Di Marco","year":"2018","unstructured":"Di Marco M, Panic EDA N, et al (2018) Which Lynch syndrome screening programs could be implemented in the real world? A systematic review of economic evaluations. Genet Med 20:1131\u20131144","journal-title":"Genet Med"},{"key":"3153_CR12","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1016\/j.cgh.2020.12.007","volume":"20","author":"M Fujita","year":"2022","unstructured":"Fujita M, Liu X, Iwasaki Y et al (2022) Population-based Screening for Hereditary Colorectal Cancer Variants in Japan. Clin Gastroenterol Hepatol 20:2132\u20132141e2139","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3153_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/jjco\/hyw178","volume":"47","author":"N Chika","year":"2017","unstructured":"Chika N, Eguchi H, Kumamoto K et al (2017) Prevalence of Lynch syndrome and Lynch-like syndrome among patients with colorectal cancer in a Japanese hospital-based population. Jpn J Clin Oncol 47:108\u2013117","journal-title":"Jpn J Clin Oncol"},{"key":"3153_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-025-02892-1","volume":"31","author":"K Tanakaya","year":"2026","unstructured":"Tanakaya K, Yamaguchi T, Hirata K et al (2026) Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2024 for the clinical practice of hereditary colorectal cancer. Int J Clin Oncol 31:1\u201366","journal-title":"Int J Clin Oncol"},{"key":"3153_CR15","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1200\/JCO.2010.30.1366","volume":"29","author":"G Hutchins","year":"2011","unstructured":"Hutchins G, Southward K, Handley K et al (2011) Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer. J Clin Oncol 29:1261\u20131270","journal-title":"J Clin Oncol"},{"key":"3153_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1056\/NEJMoa022289","volume":"349","author":"CM Ribic","year":"2003","unstructured":"Ribic CM, Sargent DJ, Moore MJ et al (2003) Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349:247\u2013257","journal-title":"N Engl J Med"},{"key":"3153_CR17","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","volume":"28","author":"DJ Sargent","year":"2010","unstructured":"Sargent DJ, Marsoni S, Monges G et al (2010) Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol 28:3219\u20133226","journal-title":"J Clin Oncol"},{"key":"3153_CR18","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1200\/JCO.20.01600","volume":"39","author":"R Cohen","year":"2021","unstructured":"Cohen R, Taieb J, Fiskum J et al (2021) Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials. J Clin Oncol 39:642\u2013651","journal-title":"J Clin Oncol"},{"key":"3153_CR19","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1200\/JCO.21.02538","volume":"40","author":"NN Baxter","year":"2022","unstructured":"Baxter NN, Kennedy EB, Bergsland E et al (2022) Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update. J Clin Oncol 40:892\u2013910","journal-title":"J Clin Oncol"},{"key":"3153_CR20","unstructured":"Drummond MFSM, Claxton K et al (2015) Methods for the Economic Evaluation of Health Care Programmes\u3010Fourth Edition\u3011. Oxford Medical Publication; UK"},{"key":"3153_CR21","first-page":"81s","volume":"18","author":"HF Vasen","year":"2000","unstructured":"Vasen HF (2000) Clinical diagnosis and management of hereditary colorectal cancer syndromes. J Clin Oncol 18:81s\u201392s","journal-title":"J Clin Oncol"},{"key":"3153_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djh034","volume":"96","author":"A Umar","year":"2004","unstructured":"Umar A, Boland CR, Terdiman JP et al (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261\u2013268","journal-title":"J Natl Cancer Inst"},{"key":"3153_CR23","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.gim.2022.01.014","volume":"24","author":"N Abu-Ghazaleh","year":"2022","unstructured":"Abu-Ghazaleh N, Kaushik V, Gorelik A et al (2022) Worldwide prevalence of Lynch syndrome in patients with colorectal cancer: Systematic review and meta-analysis. Genet Med 24:971\u2013985","journal-title":"Genet Med"},{"key":"3153_CR24","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1002\/ijc.32044","volume":"144","author":"W Jiang","year":"2019","unstructured":"Jiang W, Cai MY, Li SY et al (2019) Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features. Int J Cancer 144:2161\u20132168","journal-title":"Int J Cancer"},{"key":"3153_CR25","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1111\/jgh.14154","volume":"33","author":"DR Cenin","year":"2018","unstructured":"Cenin DR, Naber SK, Lansdorp-Vogelaar I et al (2018) Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population. J Gastroenterol Hepatol 33:1737\u20131744","journal-title":"J Gastroenterol Hepatol"},{"key":"3153_CR26","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.cgh.2013.04.044","volume":"11","author":"RN Sharaf","year":"2013","unstructured":"Sharaf RN, Myer P, Stave CD et al (2013) Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review. Clin Gastroenterol Hepatol 11:1093\u20131100","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3153_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.7326\/0003-4819-155-2-201107190-00002","volume":"155","author":"U Ladabaum","year":"2011","unstructured":"Ladabaum U, Wang G, Terdiman J et al (2011) Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med 155:69\u201379","journal-title":"Ann Intern Med"},{"key":"3153_CR28","doi-asserted-by":"crossref","unstructured":"Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group (2009) Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 11:35\u201341","DOI":"10.1097\/GIM.0b013e31818fa2ff"},{"key":"3153_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/GIM.0b013e31818fa2db","volume":"11","author":"GE Palomaki","year":"2009","unstructured":"Palomaki GE, McClain MR, Melillo S et al (2009) EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med 11:42\u201365","journal-title":"Genet Med"},{"issue":"Suppl 6","key":"3153_CR30","doi-asserted-by":"publisher","first-page":"vi73","DOI":"10.1093\/annonc\/mdt209","volume":"24","author":"J Balma\u00f1a","year":"2013","unstructured":"Balma\u00f1a J, Balaguer F, Cervantes A et al (2013) Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines. Ann Oncol 24(Suppl 6):vi73\u201380","journal-title":"Ann Oncol"},{"key":"3153_CR31","first-page":"1083","volume":"44","author":"H Kameyama","year":"2017","unstructured":"Kameyama H, Shimada Y, Yagi R et al (2017) [Quality of Life of patients after colorectal cancer surgery as assessed using EQ-5D-5L scores]. Gan Kagaku Ryoho 44:1083\u20131085","journal-title":"Gan Kagaku Ryoho"},{"key":"3153_CR32","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1016\/j.humpath.2013.06.012","volume":"44","author":"DJ Hartman","year":"2013","unstructured":"Hartman DJ, Brand RE, Hu H et al (2013) Lynch syndrome-associated colorectal carcinoma: frequent involvement of the left colon and rectum and late-onset presentation supports a universal screening approach. Hum Pathol 44:2518\u20132528","journal-title":"Hum Pathol"},{"key":"3153_CR33","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/modpathol.2016.211","volume":"30","author":"T Adar","year":"2017","unstructured":"Adar T, Rodgers LH, Shannon KM et al (2017) A tailored approach to BRAF and MLH1 methylation testing in a universal screening program for Lynch syndrome. Mod Pathol 30:440\u2013447","journal-title":"Mod Pathol"},{"key":"3153_CR34","doi-asserted-by":"publisher","first-page":"498","DOI":"10.2353\/jmoldx.2010.090212","volume":"12","author":"L P\u00e9rez-Carbonell","year":"2010","unstructured":"P\u00e9rez-Carbonell L, Alenda C, Pay\u00e1 A et al (2010) Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome. J Mol Diagn 12:498\u2013504","journal-title":"J Mol Diagn"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03153-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-026-03153-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03153-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:49:56Z","timestamp":1790354996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-026-03153-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3153"],"URL":"https:\/\/doi.org\/10.1007\/s10147-026-03153-5","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"10 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol for this research project was approved by a suitably constituted Ethics Committee of the institution and conforms to the provisions of the Declaration of Helsinki. Committee of the National Cancer Center Hospital, Approval No. 2018\u2009\u2212\u2009100. Informed consent was obtained from the participants and\/or their guardians.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all patients.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}